Pfizer’s Paxlovid Antiviral to Undergo Trial as Long Covid Medicament

Pfizer’s Paxlovid Antiviral to Undergo Trial as Long Covid Medicament

A trial is set to begin on January 1st to investigate a prime cause and cure for long Covid.


User: Veuer

Views: 3.4K

Uploaded: 2022-10-28

Duration: 01:05

Your Page Title